An experimental six-strain Lyme vaccine has demonstrated more than 70% efficacy in preventing Lyme disease in people aged ...
Sachs Media is widening its reach in the health policy space with the debut of SachsHEALTH, a new division aimed at helping ...
The Cool Down on MSN
Pfizer seeks FDA approval for new Lyme disease vaccine candidate
Vector-borne and tick-borne infections like Lyme disease have been rising sharply in recent years. Pfizer seeks FDA approval ...
An announcement from Pfizer means Lyme disease numbers could soon drop.
Scientists found that the experimental vaccine was more than 70% effective at preventing Lyme disease in a trial of nearly 10 ...
Morning Overview on MSN
Pfizer, Valneva Lyme vaccine misses primary endpoint despite efficacy
Pfizer and Valneva’s experimental Lyme disease vaccine, VLA15, failed to meet the primary endpoint of its late-stage clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results